Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|November 27, 2019
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501BSatoshi Yuki, Katsunori Shinozaki, Tomomi Kashiwada, et al.
The Oncologist|February 28, 2026
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: The BEETS (JACCRO CC‑18) studyDaisuke Kotani, Eisuke Inoue, Tadamichi Denda, et al.
Oncology|March 8, 2018
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)Hiroaki Tanioka, Yuji Miyamoto, Akihito Tsuji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2023
Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion CohortKohei Shitara, Motohiro Hirao, Satoru Iwasa, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2013
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitorsFumiaki Uehara, Aya Shoda, Keiichi Aritomo, et al.
BMC Cancer|December 16, 2022
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE studyMichio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, et al.
Journal of Clinical Medicine|February 25, 2023
Correlation of <i>UGT1A1</i> Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)Kazuaki Harada, Takahiro Yamamura, Osamu Muto, et al.
JCO Precision Oncology|January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH TrialMitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
The Oncologist|March 26, 2017
A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)Michio Nakamura, Atsushi Ishiguro, Tetsuhito Muranaka, et al.
The Oncologist|May 17, 2022
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, et al.
Pageof 12